Ubuchwepheshe be-Aptar's Activ-Film™ bukhethelwe ukuvikela ukuhlolwa okusha kwe-antigen esheshayo yakwa-SARS ukuze kutholakale ukuthi i-COVID-19

I-Crystal Lake, Illinois-(BUSINESS WIRE)-Aptar Group, Inc. (New York Stock Exchange: ATR), umholi womhlaba wonke ekulethweni kwezidakamizwa, ukusatshalaliswa komkhiqizo wabathengi kanye nezixazululo ezisebenzayo zokupakisha, umemezele ukuthi ubuchwepheshe bayo be-Activ-Film™ bukhethiwe. ukuze isetshenziswe Ukuze kuvikelwe ukuhlolwa okusha kwe-antigen esheshayo yakwa-SARS ku-COVID-19, ukuhlolwa kusanda kuthola ukugunyazwa kokusetshenziswa okuphuthumayo (i-EUA) okuvela kwa-US Food and Drug Administration (FDA).
I-Quidel® SARS Antigen Test iwukuhlolwa kwe-antigen yokunakekelwa ngokushesha okuthuthukiswe yi-Quidel® Corporation, umkhiqizi oholayo wezixazululo zokunakekelwa kwezempilo okuxilonga, futhi inganikeza imiphumela yokuhlolwa phakathi nemizuzu eyi-10.Ukuhlolwa kokufunda okubonakalayo akudingi noma yiziphi izinto ezisetshenziswayo futhi kunikeza ukufinyelela okunwetshiwe ekuhloleni i-COVID-19 okuthengekayo nokunembile, okuzosiza ukuhlangabezana nezidingo zokuhlola eziphuthumayo zomnotho womhlaba, okuhlanganisa nezidingo zokuhlola zezinhlelo zesikole nezindawo zasemaphandleni .
Ubuchwepheshe be-Aptar CSP Technologies' Activ-Film™ buhlanganiswe kukhithi yokuxilonga ukuze kuvikelwe emswakameni nezinye izimo zemvelo ezingase zithinte ukunemba kokuhlolwa.I-Active-Film™ isebenzisa ubuchwepheshe be-Aptar bezigaba ezintathu ze-Active-Polymer™, obuhlinzeka ngokuvikeleka kobunjiniyela ngokwezifiso ekucushweni okuhlukahlukene, okufana ne-Active-Vial™ ukuze kufakwe i-dipstick yokuxilonga kanye ne-Active ehlanganiswe ebhokisini lokuxilonga -Tab.Lobu buchwepheshe bokupakisha obusebenzayo obususelwa kusayensi yezinto ezibonakalayo busetshenziselwa ukuvikela i-electrochemical ehlukahlukene, ukugeleza kwe-lateral kanye namakhithi okuhlola ama-molecular diagnostic emakethe namuhla.
UMongameli we-Aptar kanye no-CEO uStephan B. Tanda uthe: “Sijabule kakhulu ukusebenzisana ne-Quidel® Corporation kuleli thuluzi elibalulekile lokuxilonga futhi sisize ukuletha i-QuickVue® SARS test antigen emakethe.”“Ubuchwepheshe bethu besayensi yezinto ezibonakalayo i-Activ-Film ™ buvikela imicu yokuhlola futhi busiza ekunikezeni imiphumela esheshayo, ethembekile.Sizoqhubeka nokusebenza ngokuhlinzeka ngezixazululo ezivikela izinsiza ezibalulekile zokuxilonga i-COVID-19, kanye nezixazululo zokusatshalaliswa kwemithi nemikhiqizo yabathengi edingwa izigidi zabantu nsuku zonke Injongo nomsebenzi emphakathini.”
U-Badre Hammond, iPhini Likamongameli Wezokusebenza Kwezohwebo kwa-Aptar CSP Technologies, uphethe ngokuthi: “Njengoba siqhubeka nokusabela enkingeni ye-COVID-19, lesi sixazululo esishintsha umdlalo sizosiza ukuhlangabezana nesidingo esiphuthumayo sokuhlolwa kwe-COVID-19 emiphakathini emhlabeni jikelele.Sizibophezele Ekuthuthukiseni ubuchwepheshe bethu besayensi yezinto zokwakha ukuze sikwazi ukusiza ozakwethu ukuthi bahlangabezane nesidingo esiqhubekayo sezixazululo ezintsha zokunakekelwa kwezempilo ukusiza ukuthuthukisa nokusindisa izimpilo. "
I-Aptar ingumholi womhlaba wonke ekwakhiweni nasekukhiqizeni ukulethwa kwezidakamizwa ezinhlobonhlobo, ukusatshalaliswa kwemikhiqizo yabathengi kanye nezixazululo ezisebenzayo zezidakamizwa.Izisombululo nezinsizakalo ze-Aptar zinikeza izimakethe ezihlukene, okuhlanganisa imithi, ubuhle, ukunakekelwa komuntu siqu, imindeni, ukudla neziphuzo.I-Aptar isebenzisa ukuqonda, ukuklama, ubunjiniyela kanye nesayensi nobuchwepheshe ukuze idale ubuchwepheshe bokupakisha bokusabalalisa, inani kanye nokuvikela kwemikhiqizo eminingi ehamba phambili emhlabeni, ngaleyo ndlela ilethe izinzuzo ezigulini nasezimpilweni zabathengi, ukubukeka, impilo, kanye namakhaya emhlabeni jikelele.Izinguquko zencazelo.I-Aptar ikomkhulu layo e-Crystal Lake, e-Illinois, futhi inabasebenzi abazinikele abangu-13,000 emazweni angu-20.Ukuze uthole olunye ulwazi, sicela uvakashele ku-www.aptar.com.
Lokhu kukhishwa kwabezindaba kuqukethe izitatimende ezibheke phambili.Izenzo ezivezwayo noma ezizayo noma ezinemibandela (ezifana nokuthi “intando”) zihloselwe ukuhlonza lezo zitatimende ezibheke phambili.Izitatimende ezibheke phambili zenziwa ngokuhambisana nezinhlinzeko zechweba eliphephile leSigaba 27A se-Securities Act ka-1933 kanye neSigaba 21E se-Securities Exchange Act ka-1934, futhi zisekelwe ezinkolelweni zethu, ekucabangeni kwethu kanye nolwazi esinalo njengamanje.Ngakho-ke, ngenxa yezingozi ezaziwayo noma ezingaziwa kanye nokungaqiniseki ekusebenzeni kwethu nendawo yebhizinisi, imiphumela yethu yangempela ingase ihluke ngokubonakalayo kuleyo evezwe noma eshiwo ezitatimendeni ezibheke phambili, okuhlanganisa kodwa kungagcini nje: ukuhlanganiswa ngempumelelo kokutholwayo;Imvelo yokulawula;kanye nokuncintisana, okuhlanganisa inqubekelaphambili yezobuchwepheshe.Ukuze uthole ulwazi olwengeziwe mayelana nalezi nezinye izingcuphe nokungaqiniseki, sicela ubheke ekugcwaliseni kwethu I-US Securities and Exchange Commission, okuhlanganisa “Izici Zobungozi” kanye “Nezingxoxo Zabaphathi Nokuhlaziywa Kwezimo Zezezimali kanye Nemiphumela Yokusebenza Efomini 10-K.”Ingxoxo ngaphansi.Futhi Ifomu 10-Q.Asithathi isibopho sokubuyekeza noma yiziphi izitatimende ezibheke phambili ngenxa yolwazi olusha, imicimbi yesikhathi esizayo noma ezinye izizathu.
Investor Relations Contact: Matt DellaMaria matt.dellamaria@aptar.com 815-479-5530 Media Contact: Katie Reardon katie.reardon@aptar.com 815-479-5671
Investor Relations Contact: Matt DellaMaria matt.dellamaria@aptar.com 815-479-5530 Media Contact: Katie Reardon katie.reardon@aptar.com 815-479-5671


Isikhathi sokuthumela: Feb-25-2021